Emlyn Samuel

Cancer Research UK
Head of Policy Development

Emlyn leads the policy development team at Cancer Research UK. His team is responsible for developing the charity''''s position on areas of public policy on a range of issues. This includes the how Government can support a thriving research environment, how cancer services are run - to diagnose patients earlier and provide better access to treatment - and how charity laws should be reformed.

His previous roles include policy positions at the Wellcome Trust, The Academy of Medical Sciences, and a secondment to the Office for Life Sciences to support the development of the Life Sciences Industrial Strategy.

dont miss

Brexit: getting the best outcome for research and patients

This seminar will discuss Cancer Research UK’s policy work on Brexit, including evidence about the impact of UK-EU collaboration and what our priorities are for negotiations about the future relationship between the UK and EU.

EVEN MORE SEMINARS

  • Prof Adam Waldman: Speaking at the Oncology Convention

    Prof Adam Waldman
    MRC Institute of Genetics & Molecular Medicine CANCER RESEARCH UK Imaging

    Biomarkers in Adult Glioma

  • Nirmesh Patel: Speaking at the Oncology Convention

    Nirmesh Patel
    Cambridge Cancer Genomics

    Monitoring cancer evolution through smart genomics and liquid biopsies

  • Rob Duncombe: Speaking at the Oncology Convention

    Rob Duncombe
    The Christie NHS Foundation Trust

    Medicine Optimisation in Oncology. How to achieve best value.

  • Professor Patricia Price: Speaking at the Oncology Convention

    Professor Patricia Price
    Action Radiotherapy

    Action Radiotherapy -a charity for radiotherapy patients and professionals.

  • Professor David Maintz: Speaking at the Oncology Convention

    Professor David Maintz
    University Hospital Cologne, Department of Radiology

    Spectral CT: Dual layer technology helps to increase diagnostic confidence